These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

249 related articles for article (PubMed ID: 18060018)

  • 1. On future's doorstep: RNA interference and the pharmacopeia of tomorrow.
    Gewirtz AM
    J Clin Invest; 2007 Dec; 117(12):3612-4. PubMed ID: 18060018
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Blocking cancer with RNA interference moves toward the clinic.
    Hede K
    J Natl Cancer Inst; 2005 May; 97(9):626-8. PubMed ID: 15870429
    [No Abstract]   [Full Text] [Related]  

  • 3. [RNA interference (RNAi) and its therapeutic potential in cancer].
    Vázquez-Vega S; Contreras-Paredes A; Lizano-Soberón M; Amador-Molina A; García-Carrancá A; Sánchez-Suárez LP; Benítez-Bribiesca L
    Rev Invest Clin; 2010; 62(1):81-90. PubMed ID: 20415062
    [TBL] [Abstract][Full Text] [Related]  

  • 4. RNA interference in biology and disease.
    Sledz CA; Williams BR
    Blood; 2005 Aug; 106(3):787-94. PubMed ID: 15827131
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chemical modification: the key to clinical application of RNA interference?
    Corey DR
    J Clin Invest; 2007 Dec; 117(12):3615-22. PubMed ID: 18060019
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Silencing of disease-related genes by small interfering RNAs.
    Fuchs U; Damm-Welk C; Borkhardt A
    Curr Mol Med; 2004 Aug; 4(5):507-17. PubMed ID: 15267222
    [TBL] [Abstract][Full Text] [Related]  

  • 7. RNA interference as a plausible anticancer therapeutic tool.
    Ramachandran PV; Ignacimuthu S
    Asian Pac J Cancer Prev; 2012; 13(6):2445-52. PubMed ID: 22938402
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Therapeutic application of RNAi: is mRNA targeting finally ready for prime time?
    Grimm D; Kay MA
    J Clin Invest; 2007 Dec; 117(12):3633-41. PubMed ID: 18060021
    [TBL] [Abstract][Full Text] [Related]  

  • 9. RNA interference: potential therapeutic targets.
    Jana S; Chakraborty C; Nandi S; Deb JK
    Appl Microbiol Biotechnol; 2004 Nov; 65(6):649-57. PubMed ID: 15372214
    [TBL] [Abstract][Full Text] [Related]  

  • 10. RNA interference: from gene silencing to gene-specific therapeutics.
    Leung RK; Whittaker PA
    Pharmacol Ther; 2005 Aug; 107(2):222-39. PubMed ID: 15908010
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Recent Advances in RNA-Targeted Cancer Therapy.
    Li M; Zhu J; Lv Z; Qin H; Wang X; Shi H
    Chembiochem; 2024 Feb; 25(4):e202300633. PubMed ID: 37961028
    [TBL] [Abstract][Full Text] [Related]  

  • 12. RNAi-based drug discovery and its application to therapeutics.
    Hokaiwado N; Takeshita F; Banas A; Ochiya T
    IDrugs; 2008 Apr; 11(4):274-8. PubMed ID: 18379962
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Therapeutic silencing of an endogenous gene by systemic administration of modified siRNAs.
    Soutschek J; Akinc A; Bramlage B; Charisse K; Constien R; Donoghue M; Elbashir S; Geick A; Hadwiger P; Harborth J; John M; Kesavan V; Lavine G; Pandey RK; Racie T; Rajeev KG; Röhl I; Toudjarska I; Wang G; Wuschko S; Bumcrot D; Koteliansky V; Limmer S; Manoharan M; Vornlocher HP
    Nature; 2004 Nov; 432(7014):173-8. PubMed ID: 15538359
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Circular RNA interference effector molecules (WO10084371).
    Lundin P; Moreno PM; Smith CI; Andaloussi SE
    Expert Opin Ther Pat; 2011 Jan; 21(1):115-9. PubMed ID: 21110768
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nonviral delivery of synthetic siRNAs in vivo.
    Akhtar S; Benter IF
    J Clin Invest; 2007 Dec; 117(12):3623-32. PubMed ID: 18060020
    [TBL] [Abstract][Full Text] [Related]  

  • 16. RNA interference-based therapeutics: new strategies to fight infectious disease.
    López-Fraga M; Wright N; Jiménez A
    Infect Disord Drug Targets; 2008 Dec; 8(4):262-73. PubMed ID: 19075801
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Therapeutic potentials of gene silencing by RNA interference: principles, challenges, and new strategies.
    Deng Y; Wang CC; Choy KW; Du Q; Chen J; Wang Q; Li L; Chung TK; Tang T
    Gene; 2014 Apr; 538(2):217-27. PubMed ID: 24406620
    [TBL] [Abstract][Full Text] [Related]  

  • 18. RNA interference for the treatment of cancer.
    Putral LN; Gu W; McMillan NA
    Drug News Perspect; 2006; 19(6):317-24. PubMed ID: 16971967
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Validation of telomerase and survivin as anticancer therapeutic targets using ribozymes and small-interfering RNAs.
    Zaffaroni N; Pennati M; Folini M
    Methods Mol Biol; 2007; 361():239-63. PubMed ID: 17172716
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Knocking down disease with siRNAs.
    Dykxhoorn DM; Lieberman J
    Cell; 2006 Jul; 126(2):231-5. PubMed ID: 16873051
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.